UPCOMING SESSIONS in ET

Thu, May 28, 2026

5:00 – 6:30 AM Bangkok

90-Minute Extended Session: TTR Inheritance, Genetic Testing & ACT-EARLY Trial Rachel Campagna Click To Register

UPCOMING SESSIONS in ET

Thu, May 28, 2026 · 5:00 – 6:30 AM Bangkok

90-Minute Extended Session: TTR Inheritance, Genetic Testing & ACT-EARLY Trial

Rachel Campagna

Click To Register

View all sessions

New AL-ISS Model Validated for Prognosis in AL Amyloidosis

Published: Feb 26, 2026

Category

Source

https://www.hematologyadvisor.com/news/al-iss-model-amyloidosis-prognosis-treatment-risk/

A new system for staging of systemic AL amyloidosis, the AL International Staging System (AL-ISS) was developed and externally validated in a study with findings reported in the Journal of Clinical Oncology.

Newsletter

RNAi Explained

Dr. Bersell explores RNA interference (RNAi) technology and its applications in treating ATTR-CM and ATTR-PN. Learn about mechanism of action, clinical evidence, and patient outcomes.

Expert Perspectives on Attruby®

Dr. Barry Trachtenberg and ATTR community members discuss Attruby™ (acoramidis), covering clinical data, patient perspectives, and treatment considerations.

Watch Discussion

Featured Trials